In the G-protein-coupled receptor (GPCR) rhodopsin, the inactivating ligand 11-cis-retinal is bound in the seven-transmembrane helix (TM) bundle and is cis/trans isomerized by light to form active metarhodopsin II. With metarhodopsin II decay, all-trans-retinal is released, and opsin is reloaded with new 11-cis-retinal. Here we present the crystal structure of ligand-free native opsin from bovine retinal rod cells at 2.9 ångström (Å ) resolution. Compared to rhodopsin, opsin shows prominent structural changes in the conserved E(D)RY and NPxxY(x) 5,6 F regions and in TM5-TM7. At the cytoplasmic side, TM6 is tilted outwards by 6-7 Å , whereas the helix structure of TM5 is more elongated and close to TM6. These structural changes, some of which were attributed to an active GPCR state, reorganize the empty retinal-binding pocket to disclose two openings that may serve the entry and exit of retinal. The opsin structure sheds new light on ligand binding to GPCRs and on GPCR activation.
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GPCRs, or seven-transmembrane receptors, constitute one of the largest superfamilies in the human genome 1 . As cell-surface receptors, GPCRs mediate responses to visual, olfactory, hormonal, neurotransmitter and other signals. Binding of small extracellular ligands modulates the capacity of GPCRs to catalyse GDP/GTP exchange in heterotrimeric guanine-nucleotide-binding proteins (G proteins) inside the cell. Rhodopsin is the eponym of the largest GPCR family 1 ; it is used in scotopic vision and is found in high concentrations in rod photoreceptor cells 2 . Light-sensitive rhodopsin consists of the apoprotein opsin and the chromophore 11-cis-retinal which is covalently bound to Lys 296 in TM7 by a protonated Schiff base. As a strong inverse agonist, 11-cis-retinal within the ligand-binding pocket stabilizes the inactive receptor state until photon absorption causes retinal cis/trans isomerization. Thereby the agonist all-trans-retinal is formed in situ, which drives the receptor to the active state. Lightinduced conformational changes are reflected in distinct photointermediates and culminate in active metarhodopsin II containing a deprotonated retinylidene Schiff base 3 . Known structural features that change with metarhodopsin II formation include breakage of constraints within the conserved E(D)RY and NPxxY(x) 5, 6 F motifs and an outward tilt of the cytoplasmic part of TM6 (refs 2-8).
The G-protein activation phase is terminated by the interaction of metarhodopsin II with rhodopsin kinase and arrestin 2 . Subsequently, the retinal Schiff base is hydrolysed and the photolysed all-transretinal is released from its binding site. Regeneration of the lightsensitive rhodopsin ground state requires the supply of new 11-cisretinal through the so-called retinoid cycle 9, 10 . As long as the retinalbinding site is empty and the opsin apoprotein waits for reconstitution with 11-cis-retinal, one experiences a reduction of visual sensitivity 9 . The reduced sensitivity reflects a background level of active G protein, which is thought to arise from a catalytically active form of opsin 9 . An active conformation of opsin, Ops*, was also found in vitro by infrared spectroscopy 11 . Several crystal structures of the 11-cis-retinal-bound rhodopsin ground state [12] [13] [14] [15] [16] , of early photointermediates 17 and of a retinal Schiff base deprotonated state 15 have been solved. A close similarity is found between all these structures, which also applies to the recently solved structures of a second GPCR, the b 2 -adrenergic receptor [18] [19] [20] . This GPCR was stabilized in the inactive state by binding of a partial inverse agonist. Protein engineering 18, 19 or binding of an antibody fragment (Fab) 20 facilitated crystallization of the b 2 -adrenergic receptor.
Ligand-free GPCRs are difficult to purify and have so far resisted attempts at their crystallization. In the case of opsin, it is known that purified opsin is unstable and tends to aggregate. An opsin mutant with increased thermal stability could be purified and formed rhodopsin on reconstitution with 11-cis-retinal 21 . This mutant rhodopsin contained a disulphide bond tethering the amino-terminal extracellular domain to the extracellular loop connecting TM6 and TM7, and allowed the first crystallization and structure determination of a recombinant GPCR 16 . Here we describe the X-ray structure of native opsin, a GPCR in its empty state, to gain insight into the uptake and release of retinal and ligand binding to GPCRs in general.
Structure of opsin
To obtain crystals of native opsin, we took a different route and optimized the extraction of bovine opsin from rod cell disc membranes, inspired by a method developed earlier for selective extraction of rhodopsin 22 . Avoiding further purification steps enabled us to obtain crystals of opsin in its native state without any modification of the protein that may cause structural distortions. For data collection, structure determination and refinement statistics, see Methods and Supplementary Table 1 .
The rhombohedral crystals contain two opsin molecules (A and B) and six b-D-octylglucoside molecules in the asymmetric unit. The final opsin model includes residues 1-326, two oligosaccharides attached to Asn 2 and Asn 15, and a palmitoylate chain attached to Cys 322 (Fig. 1) . The carboxy-terminal cytoplasmic domain of opsin (residues 327-348) is partially disordered and is not determined owing to weak electron density, whereas the transmembrane region is clearly resolved. The overall topology is similar to that of rhodopsin, with seven transmembrane-spanning helical segments connected by three cytoplasmic loops (C1 to C3) and three extracellular loops (E1 to E3), and a cytoplasmic helix (H8) adjacent to TM7 running along the membrane surface. The two monomers in the asymmetric unit are arranged as a dimer with TM1 and H8 as an interface (Fig. 1) . Similar arrangements were found in two-dimensional and three-dimensional crystals of rhodopsin 15, 23, 24 . In disc membranes, rhodopsin dimers can form as observed by atomic force microscopy, and TM4-TM5 was suggested as a dimer interface 2 . In the structures of rhodopsin and opsin, a disulphide bond between Cys 110 in TM3 and Cys 187 in loop E2 is present. Palmitoylation of opsin was clearly resolved for Cys 322 but not for Cys 323, presumably owing to the high flexibility of the fatty acid chain at Cys 323. Only ten water molecules were modelled in the refinement due to weak electron density.
Within the helix bundle, opsin shows only small changes relative to rhodopsin for TM1-TM4 (Fig. 2) , reminiscent of the proposed stable TM1-TM4 core structure that does not change much on receptor activation 25 . The most prominent change in this core is the formation of a short helical turn in loop C1 of opsin. Larger changes are observed for TM5-TM7, especially dominant at the cytoplasmic ends of these helices, causing rearrangement of loops C2 and C3 and the kink region between TM7 and H8. The N-terminal part of loop C3 adopts an a-helical structure. Therefore, TM5 is 1.5-2.5 helical turns longer in opsin than in rhodopsin, depending on the reference model. TM5 also slightly tilts in opsin, hence the cytoplasmic TM5 end is shifted by 2-3 Å towards TM6. In both opsin and rhodopsin, a kink induced by Pro 267 divides TM6 into two segments. The whole TM6 in opsin is slightly displaced away from the centre of the helix bundle. At the cytoplasmic end, TM6 is tilted outward from the helix bundle by 6-7 Å with Trp 265 as a pivot point. The cytoplasmic segment of TM6 therefore comes closer to TM5 so that it runs almost parallel to TM5. A rigid body movement of the cytoplasmic segment of TM6 was measured by electron paramagnetic resonance spectroscopy as a concomitant event during the light-induced activation of rhodopsin 4, 7 . The large outward tilt in the opsin structure of TM6 would thus indicate an active or partially active opsin conformation, in agreement with the evidence for Ops* from electrophysiological, spectroscopic and mutational analysis 9, 11, 26 . In rhodopsin, a salt bridge occurs between Arg 135 (Arg 3.50 ; superscript refers to the generalized Ballesteros-Weinstein numbering system 27 ) in TM3-which is part of the conserved E(D)RY motif in GPCRs 12 -and Glu 247 (Glu 6.30 ) in TM6. Together with Glu 134 and Thr 251, they form a more extended hydrogen-bonded network, the so-called 'ionic lock' 28 , which stabilizes TM6 within the helical bundle [12] [13] [14] (Fig. 3a) . In opsin, the ionic lock is broken and the rearranged cytoplasmic ends of TM5 and TM6 are locked by two new and F o -F c electron density maps contoured at 1.0s (blue mesh) and 2.0s (red mesh), respectively. Electron density maps were calculated using data to 4.0 Å resolution and initial molecular replacement phases, which were obtained using a truncated rhodopsin model (PDB accession 1U19) lacking both extracellular and cytoplasmic regions and TM6. The truncated initial model is shown as a green cartoon and the first Ca trace of TM6 is shown as a black ribbon. interactions (Fig. 3b) 
extended hydrogen-bonded network with Lys 231 in TM5 and Thr 251 in TM6 to stabilize the TM5 and TM6 pair at the cytoplasmic side. Glu 134 is now positioned towards TM2 and TM4 and does not seem to undergo any specific interaction (not shown). In contrast, crystal structures of early photoproducts of rhodopsin 17 , a late photoproduct with deprotonated retinal Schiff base 15 and the b 2 -adrenergic receptor bound to a partial inverse agonist [18] [19] [20] show an Arg 3.50 -Glu 6.30 distance that is only slightly larger than in rhodopsin. Compared to rhodopsin, the length and orientation of H8 remain unchanged in opsin. In opsin, TM7 deviates most from a regular a-helical structure (as in rhodopsin) and shows an even more distinct S-shape. TM7 contains the conserved NPxxY(x) 5,6 F motif 6, 12 , which links TM7 and H8 by an electrostatic interaction between the aromatic side chains of Tyr 306 (Tyr 7.53 ) and Phe 313 (Phe 7.60 ) (Fig. 4a) . The cytoplasmic end of TM7 reorganizes in opsin such that Tyr 306 rotates to face into the helix bundle (Fig. 4b) . It thereby blocks TM6 from moving back towards TM3 to adopt the conformation of rhodopsin.
Rhodopsin contains a compact extracellular domain, the so-called 'retinal plug' 29 , including two antiparallel b-sheets in the N terminus (strands b1 and b2) and loop E2 (strands b3 and b4). Loop E2 folds back into the protein to contribute residues Ser 186 to Ile 189 of strand b4 to the retinal-binding site. This whole retinal plug structure with the antiparallel b-sheets is maintained in opsin (Figs 1 and 2 ).
Within the retinal-binding pocket, the lack of the interacting prosthetic group 11-cis-retinal causes a few distinct structural alterations in the retinal-binding pocket (Fig. 5) In rhodopsin, retinal is held along the polyene chain by residues Ala 117, Thr 118, Gly 120 and Gly 121 in TM3, by Tyr 268 in TM6 and by Ser 186-Ile 189 and Tyr 191 in loop E2. In opsin, the extracellular part of TM3 and loop E2 are slightly moved away from helices TM5-TM7. Thereby, the retinal-binding pocket becomes wider towards the retinal attachment site Lys 296 and probably allows harbouring of extra water molecules. The fact that very low electron density is observed for the side chain of Lys 296 suggests that it is very flexible. Thus, the e-amino group of Lys 296 does not seem to be involved in a salt bridge with Glu 113 in TM3 or with Glu 181 in loop E2. Glu 113 is the retinal Schiff base counterion in the rhodopsin dark state; Glu 181 was proposed to be part of a complex counterion which forms in metarhodopsin I, the inactive precursor of metarhodopsin II (ref. 32) . From studies on opsin mutants it was concluded that breakage of the salt bridge between Lys 296 and Glu 113, together with sufficiently low pH, is mandatory for the activation of opsin 26 . Residues Tyr 43, Met 44 and Leu 47 in TM1, Phe 91 and Thr 94 in TM2, and Phe 293 in TM7 confine the retinal pocket around Lys 296 in rhodopsin. These residues remain unaltered in opsin except for Phe 293, in which the side chain is rotated upward by ,120u and the residue is somewhat moved away from TM1 owing to a movement of the backbone. Also, the extracellular end of TM5 and adjacent loop E2 are shifted slightly towards TM6. As mentioned previously, the retinal-binding pocket is tightly sealed by the retinal plug. Consistent with biochemical studies 21 , this argues against the idea that the plug opens in opsin to allow uptake or release of retinal from the extracellular side. 
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Retinal exchange
In contrast to rhodopsin, the opsin structure shows two openings of the retinal-binding pocket: one between the extracellular ends of TM5 and TM6, and another between TM1 and TM7 (Fig. 6a) . Owing to movement of TM6, an opening is formed by the membrane-facing residues Ile 205 and Phe 208 in TM5, and residues Phe 273 and Phe 276 in TM6 (Fig. 6a and inset 1 ). This hydrophobic hole, which is not observed in rhodopsin, is caused by small backbone movements and different side-chain orientations (Fig. 6b) . Below this opening, the extracellular ends of TM5 and TM6 are held together by a weak hydrogen bond between Glu 201 in TM5 and Gln 279 in loop E3, next to TM6. Loop E3 shows a slightly different conformation in opsin compared to rhodopsin. The second, smaller opening arises from backbone alteration in TM7 in the location of the retinal-binding pocket and the corresponding clockwise ,120u rotation of Phe 293 relative to rhodopsin (Fig. 6a and inset 2) . Thereby, a small hole between TM1 and TM7 is generated, which at the inner face of the helices can be sealed by rotamers of the Lys 296 side chain.
These two openings of the retinal-binding site hint at different retinal entrance and exit routes that were proposed for retinal channelling in opsin 33 . The opening between TM5 and TM6 could be selective for uptake of 11-cis-retinal, as outlined in the Supplementary Discussion. Regeneration of rhodopsin from the opsin apoprotein can only occur when the retinal-binding site is freed from the photolysed all-trans-retinal. When neglecting a complex bypass-that is, partial storage of retinal in metarhodopsin III (refs 34 and 35)-the first step is the hydrolysis of the retinal Schiff base. A strong increase in intrinsic fluorescence 33, 36 indicates that the interaction between the retinal b-ionone ring and Trp 265 is consequently broken. It was postulated that all-trans-retinal exits via a route that is different from the entrance route, and remains bound to an exit site 33 . The opening between TM1 and TM7 (Fig. 6a) provides a candidate for a release path for all-trans-retinal. A putative external binding site for retinal, which may also serve as an exit site, could be provided by the TM7 and H8 kink region. The retinal b-ionone ring in opsin could replace Tyr 306 (which interacts with Phe 313 in rhodopsin; Fig. 4a ), and fix Tyr 306 inside the helical bundle. Because this would stabilize TM6 in the outward position, it would also explain the partial activity when all-trans-retinal is added and forms an adduct with opsin [37] [38] [39] . Although the mechanistic aspects of these forms of opsin remain to be elucidated, their potential significance for vision makes them rewarding targets for future research. They may also have a role in disorders in the regeneration pathway, which have been associated with different forms of blindness such as Oguchi's and Stargardt's disease 9 .
Comparison with other GPCRs Rhodopsin differs from other GPCRs by its light-induced fast pathway from cis/trans retinal photoisomerization to active metarhodopsin II, and the associated formation and hydrolysis reactions of the retinal Schiff base. However, apart from this photochemical functional core, rhodopsin shows properties that also apply for GPCRs activated by diffusible ligands. GPCRs exist in multiple inactive and active conformations that are stabilized by ligands and/or G-protein 40 or pH 26, 41 . Different lines of evidence have shown that an active opsin conformation is present in the rod cell until fresh 11-cis-retinal is taken up to regenerate rhodopsin 9, 10, 42 . The amount of active Ops* is low under cellular conditions, but can be much enhanced at low pH according to a pH-dependent Ops / ? Ops* equilibrium 11, 26 . Opsin, devoid of the strongly inactivating chromophore 11-cis-retinal, thus has properties of a classical GPCR.
The proposed uptake route of retinal between the extracellular ends of TM5 and TM6 (see Supplementary Information) may also be more general for GPCRs. For example, the amine ligands of the b 2 -adrenergic receptor contain similar structures to retinal, which include a hydrophobic moiety and a terminal amino group. In the structure of the carazolol-bound b 2 -adrenergic receptor there is a short helical segment in the middle of loop E2 that is constrained by an intraloop disulphide bridge 18 . Loop E2 is in addition tethered to TM3, making it probable that the aromatic carbazole ring of carazolol enters the ligand-binding pocket at the opposite side, between TM5 and TM6. Because many ligands of GPCRs are more hydrophilic than retinal, the observed a-helix in loop E2 and the disordered N terminus in the b 2 -adrenergic receptor could have a specific role, namely of capturing diffusible ligands and providing a wider opening to allow the more hydrophilic end of ligands to enter the binding site deeper in the receptor.
Relative to inactive 11-cis-retinal-bound rhodopsin, ligand-free opsin shows large changes at the G-protein coupling surface. These changes include the outwards tilt of TM6, the elongation and sidewards shift of TM5, breakage of the ionic lock between TM3 and TM6, a broken aromatic interaction between TM7 and H8, and new interactions stabilizing TM3 and TM5, and TM5 and TM6, respectively. Some of these features were predicted to be properties of the active, G-protein-interacting metarhodopsin II state [2] [3] [4] [5] [6] [7] [8] . Retinal in rhodopsin is shown as a ball-and-stick model for reference. In opsin, Lys 296 is flexible and a rotamer was modelled for reference.
Metarhodopsin II comprises different substates with different types and degrees of activity 7 . This could explain why only small structural changes were observed in a photoactivated intermediate of rhodopsin with deprotonated retinal Schiff base 15 . Although it is conceivable that we have crystallized the active form of opsin, Ops*, we do not know whether the features we have found comprise the whole structural arsenal that is required to activate the G protein. Only the structure of the complex between light-activated rhodopsin and the G protein or peptides derived from its receptor interacting domains will provide an answer to this question.
METHODS SUMMARY
Native opsin was prepared from bovine eyes and extracted from rod outersegment disc membranes using b-D-octylglucopyranoside. Without further purification, solubilized opsin was crystallized by hanging-drop vapour diffusion in a mixture of ammonium sulphate and MES or sodium acetate buffer at pH 5.6. Crystals grown within 7 days were cryoprotected in 10% trehalose and frozen in liquid nitrogen for X-ray analysis at the synchrotron BESSY (Berlin, Germany). The opsin structure was solved by molecular replacement using several models of rhodopsin monomers (Protein Data Bank (PDB) accessions 1U19, 1GZM and 1HZX) without cytoplasmic and extracellular regions as initial search trials.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
